Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
The Pharmacogenomics Journal|July 11, 2024
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertensionJulia C F Quintanilha, William Kevin Kelly, Federico Innocenti
Human Mutation|March 26, 2011
Genetic Analysis in Translational Medicine: The 2010 GOLDEN HELIX SymposiumGeorge P Patrinos, Federico Innocenti, Nancy Cox, et al.
Drug Metabolism Reviews|June 12, 2009
Clinical pharmacology and pharmacogenetics of gemcitabineAndrea Wong, Ross A Soo, Wei-Peng Yong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymesWei Peng Yong, Jacqueline Ramirez, Federico Innocenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
Reply to A. Sartore-Bianchi et alFrancesca Battaglin, Fang-Shu Ou, Federico Innocenti, et al.
Toxicology and Applied Pharmacology|February 16, 2005
5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in miceFederico Innocenti, Romano Danesi, Guido Bocci, et al.
Personalized Medicine|April 25, 2020
Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?Maria Koromina, Valentini Konstantinidou, Malvina Georgaka, et al.
Pharmacogenetics and Genomics|July 12, 2007
UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human liversAndrea L Yoder Graber, Jacqueline Ramírez, Federico Innocenti, et al.
BMC Bioinformatics|June 15, 2019
fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studiesJiaxing Lin, Alexander Sibley, Ivo Shterev, et al.
Pharmacogenomics|July 17, 2009
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecanJanelle M Hoskins, Gary L Rosner, Mark J Ratain, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
The Pharmacogenomics Journal|July 11, 2024
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertensionJulia C F Quintanilha, William Kevin Kelly, Federico Innocenti
Human Mutation|March 26, 2011
Genetic Analysis in Translational Medicine: The 2010 GOLDEN HELIX SymposiumGeorge P Patrinos, Federico Innocenti, Nancy Cox, et al.
Drug Metabolism Reviews|June 12, 2009
Clinical pharmacology and pharmacogenetics of gemcitabineAndrea Wong, Ross A Soo, Wei-Peng Yong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymesWei Peng Yong, Jacqueline Ramirez, Federico Innocenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
Reply to A. Sartore-Bianchi et alFrancesca Battaglin, Fang-Shu Ou, Federico Innocenti, et al.
Toxicology and Applied Pharmacology|February 16, 2005
5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in miceFederico Innocenti, Romano Danesi, Guido Bocci, et al.
Personalized Medicine|April 25, 2020
Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?Maria Koromina, Valentini Konstantinidou, Malvina Georgaka, et al.
Pharmacogenetics and Genomics|July 12, 2007
UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human liversAndrea L Yoder Graber, Jacqueline Ramírez, Federico Innocenti, et al.
BMC Bioinformatics|June 15, 2019
fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studiesJiaxing Lin, Alexander Sibley, Ivo Shterev, et al.
Pharmacogenomics|July 17, 2009
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecanJanelle M Hoskins, Gary L Rosner, Mark J Ratain, et al.
Pageof 19